BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 11445440)

  • 1. The isoprostanes in biology and medicine.
    Praticò D; Lawson JA; Rokach J; FitzGerald GA
    Trends Endocrinol Metab; 2001 Aug; 12(6):243-7. PubMed ID: 11445440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases.
    Praticò D; Rokach J; Lawson J; FitzGerald GA
    Chem Phys Lipids; 2004 Mar; 128(1-2):165-71. PubMed ID: 15037161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. F(2)-isoprostanes: sensitive and specific non-invasive indices of lipid peroxidation in vivo.
    Praticò D
    Atherosclerosis; 1999 Nov; 147(1):1-10. PubMed ID: 10525118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isoprostanes: new markers of oxidative stress. Fundamental and clinical aspects].
    Cracowski JL; Stanke-Labesque F; Bessard G
    Rev Med Interne; 2000 Mar; 21(3):304-7. PubMed ID: 10763198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isoprostanes: unique bioactive products of lipid peroxidation.
    Morrow JD; Roberts LJ
    Prog Lipid Res; 1997 Mar; 36(1):1-21. PubMed ID: 9373618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease.
    Patrono C; FitzGerald GA
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2309-15. PubMed ID: 9409197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isoprostanes: their quantification as an index of oxidant stress status in vivo.
    Morrow JD
    Drug Metab Rev; 2000; 32(3-4):377-85. PubMed ID: 11139135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular biology of the isoprostanes.
    Cracowski JL; Devillier P; Durand T; Stanke-Labesque F; Bessard G
    J Vasc Res; 2001; 38(2):93-103. PubMed ID: 11316945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Isoprostanes: new markers of oxidative stress in human diseases].
    Cracowski JL; Stanke-Labesque F; Souvignet C; Bessard G
    Presse Med; 2000 Mar; 29(11):604-10. PubMed ID: 10776418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury.
    Roberts LJ; Morrow JD
    Ann N Y Acad Sci; 1994 Nov; 744():237-42. PubMed ID: 7825845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
    Praticò D; Iuliano L; Mauriello A; Spagnoli L; Lawson JA; Rokach J; Maclouf J; Violi F; FitzGerald GA
    J Clin Invest; 1997 Oct; 100(8):2028-34. PubMed ID: 9329967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
    Piłacik B; Nofer TW; Wasowicz W
    Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprostanes: novel bioactive products of lipid peroxidation.
    Basu S
    Free Radic Res; 2004 Feb; 38(2):105-22. PubMed ID: 15104204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isoprostanes and the kidney.
    Badr KF; Abi-Antoun TE
    Antioxid Redox Signal; 2005; 7(1-2):236-43. PubMed ID: 15650411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells.
    Yura T; Fukunaga M; Khan R; Nassar GN; Badr KF; Montero A
    Kidney Int; 1999 Aug; 56(2):471-8. PubMed ID: 10432385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
    Morrow JD; Awad JA; Boss HJ; Blair IA; Roberts LJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10721-5. PubMed ID: 1438268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved method for the measurement of urinary and plasma F2-isoprostanes using gas chromatography-mass spectrometry.
    Mori TA; Croft KD; Puddey IB; Beilin LJ
    Anal Biochem; 1999 Mar; 268(1):117-25. PubMed ID: 10036170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
    Mezzetti A; Cipollone F; Cuccurullo F
    Cardiovasc Res; 2000 Aug; 47(3):475-88. PubMed ID: 10963721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of monohydroxyeicosatetraenoic acids and F2-isoprostanes as markers of lipid peroxidation in rat brain mitochondria.
    Wiswedel I; Hirsch D; Nourooz-Zadeh J; Flechsig A; Lück-Lambrecht A; Augustin W
    Free Radic Res; 2002 Jan; 36(1):1-11. PubMed ID: 11999696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.